Patented Medicine Prices Review Board
The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive, and by reporting on pharmaceutical trends.
We are in the process of moving our services and information to Canada.ca.
Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.
Our services and information
Search for new patented medicines reported to the PMPRB by keyword, status, and/or year reported.
Find information on the PMPRB’s regulatory and investigative process.
Find information on the PMPRB’s statutory reporting requirements, guidance on filing requirements and deadlines for patentees, outreach presentations and recorded Webinar sessions, and answers to frequently-asked questions.
Find information on key trends in sales and prices of patented drug products, and in drug manufacturers’ investments in pharmaceutical research and development.
Find information on the PMPRB’s hearing process, the status of ongoing proceedings, and a listing of Board decisions and orders.
What we are doing
Laws and regulations
- DIP Methodology Technical Working Group
- Consumer price index (CPI) initiative
- Regulatory burden reduction
- Proposed changes to the Compendium of policies, Guidelines and procedures
The Patented Medicine Prices Review Board is responsible for ensuring the prices that patentees charge for prescription and non-prescription patented medicines sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use, are not excessive.
The Patented Medicine Prices Review Board reports annually to Parliament through the Minister of Health on its price review activities, the prices of patented medicines and price trends of all prescription drugs, and on the research-and-development expenditures reported by pharmaceutical patentees.
National Prescription Drug Utilization Information System (NPDUIS)
The National Prescription Drug Utilization Information System (NPDUIS) is a research initiative jointly conducted by the Patented Medicine Prices Review Board and the Canadian Institute for Health Information. NPDUIS provides policy-makers and drug plan managers with information and insight on trends in pharmaceutical prices, use, and costs.
Report a problem or mistake on this page
- Date modified: